Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: solidify (1), become firm (41), set (912), freeze (57), consolidate (23), become settled (107)

Azacitidine(SC)-Venetoclax

Description: Chemotherapy Protocol Acute Myeloid Leukaemia AZACITIDINE (SC) - VENETOCLAX Regimen  AML – Azacitidine (SC) - Venetoclax Indication  Newly diagnosed acute myeloid leukaemia (AML).  Patient
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AzacitidineSC-Venetoclax.pdf

Azacitidine5

Description: Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5 days) This is an unlicensed
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5.pdf

Azacitidine5+2Ver1

Description: Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5+2 days) This is not
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5-2Ver1.pdf

Follow up after breast cancer - patient information

Description: This booklet explains what self-supported management is after treatment for early breast cancer and how it works.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Follow-up-after-breast-cancer-1107-PIL.pdf

Systemic anti-cancer therapy (SACT) extravasation - patient information

Description: This factsheet explains what systemic anti-cancer therapy (SACT) extravasation is, what causes it and the signs you need to be
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Systemic-anti-cancer-therapy-SACT-extravasation-3918-PIL.pdf

Bulevirtide (Hepcludex®) for the treatment of chronic hepatitis D - patient information

Description: This factsheet explains what bulevirtide (Hepcludex®) is, how it is given to treat hepatitis D and the possible side effects.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Bulevirtide-Hepcludex®-for-the-treatment-of-chronic-hepatitis-D-3673-PIL.pdf

Radiotherapy for pituitary tumours - patient information

Description: This booklet contains information for patients who have been recommended radiotherapy treatment for a pituitary tumour.
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Radiotherapy-for-pituitary-tumours-3290-PIL.pdf

Whole cranio-spinal radiotherapy - patient information

Description: This factsheet explains what whole cranio-spinal radiotherapy is and what to expect during treatment.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Whole-cranio-spinal-radiotherapy-1704-PIL.pdf

Papers Trust Board - 11 March 2025

Description: Date Time Location Chair Agenda Trust Board – Open Session 11/03/2025 9:00 - 13:00 Conference Room, Heartbeat Education Centre
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-11-March-2025.pdf

Papers Trust Board - 13 May 2025

Description: Agenda Trust Board – Open Session Date Time Location Chair Apologies In attendance 13/05/2025 9:00 - 13:0
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-13-May-2025.pdf

1 to 10 of 10